Cargando…

Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells

The anticancer small molecule MLN4924, a Nedd8-activating enzyme (NAE) inhibitor, triggers cell-cycle arrest, apoptosis, and senescence in cancer cells. In this study, we demonstrate that MLN4924 suppresses osteosarcoma cell proliferation by inducing G2/M cell cycle arrest and apoptosis. Our results...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shuju, Zhang, Jiaming, Deng, Zhiyuan, Liu, Huadie, Mao, Wei, Jiang, Fang, Xia, Zanxian, Li, Jia-Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323217/ https://www.ncbi.nlm.nih.gov/pubmed/27602774 http://dx.doi.org/10.18632/oncotarget.11807

Ejemplares similares

MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2016)

Broad and potent antiviral activity of the NAE inhibitor MLN4924
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2016)

The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance
por: Du, Meng-ge, et al.
Publicado: (2021)

The use of the NEDD8 inhibitor MLN4924 (Pevonedistat) in a cyclotherapy approach to protect wild-type p53 cells from MLN4924 induced toxicity
por: Malhab, Lara J. Bou, et al.
Publicado: (2016)

Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1
por: Mao, Hongmei, et al.
Publicado: (2019)

The circadian clock component BMAL1 regulates osteogenesis in osseointegration
por: Deng, Shiyong, et al.
Publicado: (2022)

Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib
por: Yang, Zelong, et al.
Publicado: (2019)

Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment
por: Misra, Shrilekha, et al.
Publicado: (2020)

BMAL1 and CLOCK, Two Essential Components of the Circadian Clock, Are Involved in Glucose Homeostasis
por: Rudic, R. Daniel, et al.
Publicado: (2004)

The NAE inhibitor pevonedistat (MLN4924) synergizes with TNF-α to activate apoptosis
por: Wolenski, F S, et al.
Publicado: (2015)

Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy
por: Aubry, Arthur, et al.
Publicado: (2020)

The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells
por: Zhang, Huilin, et al.
Publicado: (2021)

The novel protective role of P27 in MLN4924-treated gastric cancer cells
por: Zhang, Q, et al.
Publicado: (2015)

Circadian Clock Component BMAL1 in the Paraventricular Nucleus Regulates Glucose Metabolism
por: Nakata, Masanori, et al.
Publicado: (2021)

Circadian key component CLOCK/BMAL1 interferes with segmentation clock in mouse embryonic organoids
por: Umemura, Yasuhiro, et al.
Publicado: (2021)

Regulation of circadian clock transcriptional output by CLOCK:BMAL1
por: Trott, Alexandra J., et al.
Publicado: (2018)

Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells
por: Lan, Huiyin, et al.
Publicado: (2016)

Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer
por: Ferris, Jennifer, et al.
Publicado: (2020)

Inhibiting Neddylation with MLN4924 Suppresses Growth and Delays Multicellular Development in Dictyostelium discoideum
por: Huber, Robert J., et al.
Publicado: (2021)

MLN4924 inhibits cell proliferation by targeting the activated neddylation pathway in endometrial carcinoma
por: Liu, Huanrong, et al.
Publicado: (2021)

MLN4924 Promotes Self-Renewal of Limbal Stem Cells and Ocular Surface Restoration
por: Li, Qingjian, et al.
Publicado: (2023)

BMAL1 dephosphorylation determines the pace of the circadian clock
por: Schibler, Ueli
Publicado: (2021)

The circadian clock components BMAL1 and REV-ERBα regulate flavivirus replication
por: Zhuang, Xiaodong, et al.
Publicado: (2019)

The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice
por: Yu, Huilin, et al.
Publicado: (2022)

Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin
por: Gu, Shanshan, et al.
Publicado: (2023)

Interaction of circadian clock proteins PER2 and CRY with BMAL1 and CLOCK
por: Langmesser, Sonja, et al.
Publicado: (2008)

Cardioprotective effect of MLN4924 on ameliorating autophagic flux impairment in myocardial ischemia-reperfusion injury by Sirt1
por: Zhang, Ji, et al.
Publicado: (2021)

Opposite Carcinogenic Effects of Circadian Clock Gene BMAL1
por: Korkmaz, Tuba, et al.
Publicado: (2018)

The Circadian Clock Gene BMAL1 Coordinates Intestinal Regeneration
por: Stokes, Kyle, et al.
Publicado: (2017)

Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells
por: Wang, Xiaofang, et al.
Publicado: (2016)

Disruption of the Clock Components CLOCK and BMAL1 Leads to Hypoinsulinemia and Diabetes
por: Marcheva, Biliana, et al.
Publicado: (2010)

Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus
por: Chang, Pey-Jium, et al.
Publicado: (2017)

REGγ regulates circadian clock by modulating BMAL1 protein stability
por: Kubra, Syeda, et al.
Publicado: (2021)

Effects of BMAL1 Manipulation on the Brain’s Master Circadian Clock and Behavior
por: Haque, Samreen N., et al.
Publicado: (2019)

Deficiency of the Circadian Clock Gene Bmal1 Reduces Microglial Immunometabolism
por: Wang, Xiao-Lan, et al.
Publicado: (2020)

Emerging Insight Into the Role of Circadian Clock Gene BMAL1 in Cellular Senescence
por: Zhang, Wenqian, et al.
Publicado: (2022)

Circadian clock gene Clock-Bmal1 regulates cellular senescence in Chronic obstructive pulmonary disease
por: Li, Lingling, et al.
Publicado: (2022)

Protein phosphatase 4 controls circadian clock dynamics by modulating CLOCK/BMAL1 activity
por: Klemz, Sabrina, et al.
Publicado: (2021)

MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma
por: Tong, Shuai, et al.
Publicado: (2017)

Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma
por: Xiong, Shida, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qupeii4j6012c6scusn1olg29i